Sponsor or institution
Clinical trials and research at Nerx Biosciences, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $2.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
New cancer treatment aimed at the DNA damage sensor Replication Protein A (RPA)
A company is creating a new cancer medicine that blocks a DNA repair sensor called RPA to help kill tumors that depend on DNA repair.
-
Targeting a key protein involved in DNA damage response for cancer therapy
This study is exploring a new cancer treatment that aims to make cancer cells more vulnerable by blocking a protein called RPA, which helps them survive when their DNA is damaged, and it's designed for patients with tumors that have trouble repairing their DNA.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.